Faisal Humayun

Faisal Humayun

InvestorPlace Contributor

Expertise: Oil and Gas, Electric Vehicles, Emerging Growth Stories

Education: Bachelor of Science, MBA with Specialization in Finance

About Faisal:
Faisal Humayun is an MBA in Finance and a senior research analyst with 14 years of experience in the field of equity, credit, industry and economic research. While working as a senior analyst, he has been involved in financial modelling, valuation analysis and credit rating.

As a freelancer, Faisal has authored over 1,500 articles for various publications that include Seeking Alpha, GuruFocus, Motley Fool, Trading Ideas and Red Pulse. His primary focus is on fundamental analysis using the top-down as well as bottom-up approach to stock selection.

Faisal is also an active trader with focus on price action trading strategy. A combination of long-term investing and short-term trading has produced decent results in a decade long exposure to equity markets. However, his favorite asset class is precious metals.

Additionally, Faisal has been researching cryptocurrencies in the last few quarters. His focus is not on the blue-chip coins, but on emerging altcoins that can be value creators.

You can learn more about Faisal at his profile on LinkedIn.

Recent Articles

4 Stocks To Sell If Covid-19 Hurts Oil Demand Again

By Faisal Humayun, InvestorPlace Contributor

Another wave of Covid-19 could result in a double-dip recession, hurting leveraged oil companies. Put these on your list of stocks to sell.

4 Top Robotics Stocks to Buy for 2021

By Faisal Humayun, InvestorPlace Contributor

Top robotics stocks for 2021 and beyond. These stocks come with a focus on consumer, healthcare and industrial sectors.

4 Stocks to Buy That Reported Stellar Earnings

By Faisal Humayun, InvestorPlace Contributor

The earnings season has been mixed. These four stocks to buy reported strong earnings and are likely to be out-performers.

At This Point, Go Ahead and Count Inovio Pharmaceuticals Out of the Vaccine Race

By Faisal Humayun, InvestorPlace Contributor

INO stock is a purely speculative bet. I don't see the company being among the few that deliver a vaccine against Covid-19.

4 Entertainment Stocks Looking Forward to the Holidays

By Faisal Humayun, InvestorPlace Contributor

With the pandemic raging out of control, investors should consider in-house entertainment stocks as as good bets for the holiday season.

3 Pharmaceutical Stocks to Buy in November

By Faisal Humayun, InvestorPlace Contributor

Here are pharmaceutical stocks for November 2020 with a focus on companies that are close to delivering a vaccine against Covid-19.

4 Energy Stocks Ready to Ride Out the Sector’s Troubles

By Faisal Humayun, InvestorPlace Contributor

These energy stocks are likely to make a turnaround in 2021 as global growth accelerates and oil price trends higher.

I Would Not Be Surprised If SRNE Stock Trades Below $5

By Faisal Humayun, InvestorPlace Contributor

SRNE stock is a purely speculative bet. The company has a deep pipeline of Covid-19 programs. But there is little progress or positive outcome.

4 Strong Value Stocks for Savvy Investors Seeking 2021 Winners

By Faisal Humayun, InvestorPlace Contributor

Take a look at four value stocks from sectors that have underperformed lately. In addition to valuations, these stocks have robust dividend yield.

4 New Stocks To Buy On Robinhood Stocks Watchlists

By Faisal Humayun, InvestorPlace Contributor

The millenial-favorite trading platform is a good place to find names with high growth potential. Check out new stocks to buy favored by Robinhood traders.

Load More